Collins Daisy E, Ellis Sarah J, Janin Madeleine M, Wakefield Claire E, Bussey Kay, Cohn Richard J, Lah Suncica, Fardell Joanna E
1 Sydney Children's Hospital, Sydney, New South Wales, Australia.
2 University of New South Wales, Sydney, New South Wales, Australia.
J Pediatr Oncol Nurs. 2019 Jan/Feb;36(1):55-68. doi: 10.1177/1043454218810136. Epub 2018 Nov 8.
One in four school-aged children is bullied. However, the risk may be greater for childhood cancer patients/survivors (diagnosed <18 years), because of symptoms of the disease and treatment that may prejudice peers. While the serious consequences of bullying are well documented in the general population, bullying may have even greater impact in children with cancer due to the myriad of challenges associated with treatment and prolonged school absence.
To summarize the state of evidence on bullying in childhood cancer patients/survivors; specifically, the rate and types of bullying experienced and the associated factors.
We searched five electronic databases from inception to February 2018 for original research articles reporting on bullying in childhood cancer patients/survivors.
We identified 29 eligible articles, representing 1,078 patients/survivors ( M = 14.35 years). Self-reports from patients/survivors revealed a considerably higher rate of bullying (32.2%) compared with the general population (25%). Our review identified little information on the factors associated with bullying in patients/survivors. However, the bullying described tended to be verbal and was often related to the physical side effects of treatment, indicating that differences in appearance may prejudice peers. It was further suggested that educating the child's classmates about cancer may prevent bullying.
Our findings confirm that bullying is a significant challenge for many childhood cancer patients/survivors. Additional studies are needed to identify factors that may influence the risk of bullying, which will inform the development of evidence-based interventions and guidelines to prevent bullying in childhood cancer patients/survivors.
四分之一的学龄儿童遭受过欺凌。然而,儿童癌症患者/幸存者(18岁前被诊断)面临的风险可能更大,因为疾病症状和治疗可能会使同龄人产生偏见。虽然欺凌的严重后果在普通人群中有充分记录,但由于与治疗相关的众多挑战以及长期缺课,欺凌对癌症患儿的影响可能更大。
总结儿童癌症患者/幸存者中欺凌现象的证据状况;具体而言,是遭受欺凌的比率和类型以及相关因素。
我们检索了五个电子数据库,从建库至2018年2月,查找关于儿童癌症患者/幸存者中欺凌现象的原创研究文章。
我们确定了29篇符合条件的文章,代表1078名患者/幸存者(平均年龄M = 14.35岁)。患者/幸存者的自我报告显示,遭受欺凌的比率(32.2%)比普通人群(25%)高得多。我们的综述发现关于患者/幸存者中与欺凌相关因素的信息很少。然而,所描述的欺凌往往是言语上的,并且常常与治疗的身体副作用有关,这表明外貌差异可能会使同龄人产生偏见。进一步建议对孩子的同学进行癌症教育可能会防止欺凌。
我们的研究结果证实,欺凌对许多儿童癌症患者/幸存者来说是一项重大挑战。需要进一步的研究来确定可能影响欺凌风险的因素,这将为制定基于证据的干预措施和指南提供依据,以防止儿童癌症患者/幸存者遭受欺凌。